These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25633242)

  • 21. New developments in gout.
    Harrold L
    Curr Opin Rheumatol; 2013 May; 25(3):304-9. PubMed ID: 23466959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability.
    Dalbeth N; Petrie KJ; House M; Chong J; Leung W; Chegudi R; Horne A; Gamble G; McQueen FM; Taylor WJ
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1605-12. PubMed ID: 22034122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-titration of allopurinol in patients with gout.
    Jennings CG; Mackenzie IS; Flynn R; Ford I; Nuki G; De Caterina R; Riches PL; Ralston SH; MacDonald TM;
    Semin Arthritis Rheum; 2014 Aug; 44(1):25-30. PubMed ID: 24560169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician adherence to ACR gout treatment guidelines: perception versus practice.
    Oderda GM; Shiozawa A; Walsh M; Hess K; Brixner DI; Feehan M; Akhras K
    Postgrad Med; 2014 May; 126(3):257-67. PubMed ID: 24918810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation and treatment of gout as a chronic disease.
    Perez-Ruiz F; Herrero-Beites AM
    Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with initiation and persistence of urate-lowering therapy.
    Dehlin M; Ekström EH; Petzold M; Strömberg U; Telg G; Jacobsson LT
    Arthritis Res Ther; 2017 Jan; 19(1):6. PubMed ID: 28095891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The patient's experience of gout: new insights to optimize management.
    Dalbeth N; Lindsay K
    Curr Rheumatol Rep; 2012 Apr; 14(2):173-8. PubMed ID: 22198831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to urate-lowering therapy.
    Day RO
    South Med J; 2009 Jan; 102(1):114-5. PubMed ID: 19077754
    [No Abstract]   [Full Text] [Related]  

  • 29. Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?
    Coleshill MJ; Aung E; Carland JE; Faasse K; Stocker S; Day RO
    Ther Innov Regul Sci; 2021 Jan; 55(1):138-141. PubMed ID: 32661926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An appraisal of the 2012 American College of Rheumatology Guidelines for the Management of Gout.
    Nuki G
    Curr Opin Rheumatol; 2014 Mar; 26(2):152-61. PubMed ID: 24492863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How Can We Improve Disease Education in People with Gout?
    Fields TR; Batterman A
    Curr Rheumatol Rep; 2018 Mar; 20(3):12. PubMed ID: 29516200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric evaluation of the Adherence to Refills and Medications Scale (ARMS) in Australians living with gout.
    Schulz M; Day RO; Coleshill MJ; Briggs NE; Aung E
    Clin Rheumatol; 2024 Sep; 43(9):2943-2954. PubMed ID: 39008222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to Care in Gout: From Prescriber to Patient.
    Vaccher S; Kannangara DR; Baysari MT; Reath J; Zwar N; Williams KM; Day RO
    J Rheumatol; 2016 Jan; 43(1):144-9. PubMed ID: 26568590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.
    Schumacher HR; Evans RR; Saag KG; Clower J; Jennings W; Weinstein SP; Yancopoulos GD; Wang J; Terkeltaub R
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1462-70. PubMed ID: 22549879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic gout: Barriers to effective management.
    Rogenmoser S; Arnold MH
    Aust J Gen Pract; 2018 Jun; 47(6):351-356. PubMed ID: 29966174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are Doctors the Best People to Manage Gout? Is There a Role for Nurses and Pharmacists?
    Latif Z; Abhishek A
    Curr Rheumatol Rep; 2018 Mar; 20(3):14. PubMed ID: 29516289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urate-lowering therapy adherence and the association with medication beliefs, self-efficacy, depression, anxiety, and COVID-19 pandemic-related concern in Chinese gout patients: a cross-sectional study.
    Yin R; Lu J; Xu Z; Yan Q; Wang M; Xu R
    Psychol Health Med; 2023; 28(7):1698-1708. PubMed ID: 37322811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gout in a rheumatology clinic: results of EULAR/ACR guidelines-compliant treatment.
    Slot O
    Scand J Rheumatol; 2018 May; 47(3):194-197. PubMed ID: 28891365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term adherence and persistence with febuxostat among male patients with gout in a routine clinical setting.
    Lee S; So MW; Ahn E
    Mod Rheumatol; 2019 Jul; 29(4):662-668. PubMed ID: 29856667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.